Deadline: 18-Aug-20
The BRICS STI Framework Programme aims to support excellent research on priority areas which can best be addressed by a multinational approach. The initiative should facilitate cooperation among the researchers and institutions in the consortia which consist of partners from at least three of the BRICS countries.
Thematic Areas
- Research and development of new technologies/tools for diagnosing COVID-19.
- Research and development of COVID-19 vaccines and drugs, including repurposing of available drugs.
- Genomic sequencing of SARS-CoV-2 and studies on the epidemiology and mathematical modelling of the COVID-19 pandemic.
- AI, ICT and HPC oriented research for COVID-19 drugs design, vaccine development, treatment, clinical trials and public health infrastructures and systems.
- Epidemiological studies and clinical trials to evaluate the overlap of SARS-CoV-2 and comorbidities, especially tuberculosis.
Eligibility Criteria
- Indian Entities Eligible to Participate
- The participating entities/organisations from India have to be a legal entity as per Indian law (Indian applicants) The Indian entities eligible to participate include:
- Government of India supported or recognised (Public or Private) academia; research; organisations and urban or other local bodies;
- Government of India recognised not-for-profit, NGO(s)/ VO(s)/ Trust(s)/ Research foundations, having research as one of the imperative mandates;
- Indian Industry can be a partner in the consortium and are eligible for funding subject to fulfilment of DST/DBT’s technical, administrative and financial norms.
- The participating entities/organisations from India have to be a legal entity as per Indian law (Indian applicants) The Indian entities eligible to participate include:
- Academic/Research Partners
- Public and/or private universities and research organisations must have a well established research support system, for basic or applied research;
- Submission of proof of establishment under Indian statue; recognition documents and registration at Government of India’s Public Finance Management System (PFMS) shall be obligatory.
- NGO(s)/VO(s)/Trust(s)/Research Foundations
- The Indian private R&D performing institutions and Not-for-profit, NGO(s)/ VO(s)/ Trust(s)/ Research foundations should have experience of at least 3 years in scientific research, teaching, training and extension activities; and must follow research as one of the mandates.
- Proof of registration at ‘NGO DARPAN’ of NITI Aayog, Certificate of registration under Society Registration Act, Firm’s Memorandum of Association, Registration at Government of India’s Public Finance Management System (PFMS), Valid SIRO certificate for firm’s in-house R&D recognition and audited account statements for the past three years shall be obligatory;
- Industry partners
- Should be an Indian Company registered under the Companies Act, wherein 51% (or more) of the ownership/shareholding/partnerships shall be held by resident Indian citizen(s); should be complying with General Financial Rules (GFR), 2017;
- Submission of Certificate of Incorporation issued under Companies Act, Valid SIRO certificate for firm’s in-house R&D recognition, Exemption Certificate (as applicable), Firm’s Memorandum of Association, registration at Government of India’s Public Finance Management System (PFMS) and Audited Account Statements for the past three years shall be obligatory.
Ineligible Organisations
- Companies headquartered and owned outside India and their subsidiaries in India, or vice versa, are not eligible to receive funding from DST/DBT under this action;
- Research centres and academic organisations headquartered and owned outside India and their subsidiaries in India, or vice versa, are not eligible to receive funding from DST/DBT under this programme.
For more information, visit https://dst.gov.in/callforproposals/brics-covid-19-call-application
